PP
ANAC

Paloma Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Paloma Partners’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,946
Closed -$371K – 2521
2016
Q1 		$371K Buy
+6,946
New +$513K 0.01% 1454

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Paloma Partners's ANAC Position: Q2 2016 in Review

Paloma Partners sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 6,946 shares — an estimated $371K sold.

Paloma Partners first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $371K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Paloma Partners reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Paloma Partners sold 6,946 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $371K.
  • Paloma Partners first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
  • Paloma Partners's ANACOR PHARMACEUTICALS INC COM position peaked at $371K in Q1 2016.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Paloma Partners's 13F filing for Q2 2016, filed 15 Aug 2016.